Meropenem and Meloxicam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meropenem (meropenem) and Meloxicam (meloxicam). Common drug interactions include thrombocytopenia among females and acute generalised exanthematous pustulosis among males.

The phase IV clinical study analyzes what interactions people have when they take Meropenem and Meloxicam. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,017 Meloxicam users. Check the latest studies of Meloxicam.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

64 people who take Meropenem and Meloxicam together, and have interactions are studied.

Meropenem and Meloxicam drug interactions.

What are the common drug interactions of Meropenem and Meloxicam, by gender? *:

female:

Thrombocytopenia (decrease of platelets in blood)
Urinary tract infection
Abscess limb (limb infection)
Cellulitis (infection under the skin)
Cervical cord compression (compression of spinal cord at site of cervical vertebrae)
Gait disturbance
Muscular weakness (muscle weakness)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Perirectal abscess
Rash

male:

Acute generalised exanthematous pustulosis (acute febrile drug eruption)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood culture positive
Haematocrit decreased
Haemoglobin decreased
White blood cell count decreased
Oropharyngeal pain
Hypertension (high blood pressure)
Pustular psoriasis (raised bumps on the skin that are filled with pus)
Acute respiratory failure

What are the common drug interactions of Meropenem and Meloxicam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Acute respiratory failure
Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Cardiovascular insufficiency (inadequate functioning of heart)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Hallucination (an experience involving the perception of something not present)
Hypertension (high blood pressure)
Hypoxia (low oxygen in tissues)
Pulmonary oedema (fluid accumulation in the lungs)
Tachypnoea (a condition of rapid breathing over 20 per minute)

20-29:

n/a

30-39:

n/a

40-49:

Cough
Diarrhoea
Hypokalaemia (low potassium)
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Pruritus (severe itching of the skin)
Chronic kidney disease
Dermatitis allergic (inflammation of the skin due allergic reaction)
Drug eruption (adverse drug reaction of the skin)
Granulocyte count decreased
White blood cell count decreased

50-59:

Blood albumin decreased
Blood calcium increased
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Cellulitis (infection under the skin)
Cellulitis of male external genital organ (infection of male genitals soft tissue)
Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
Fatigue (feeling of tiredness)
Genital abscess (build up of pus in genital)
Groin abscess (pus in groin)
Haematocrit decreased

60+:

Acute generalised exanthematous pustulosis (acute febrile drug eruption)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Lethargy (tiredness)
Back pain
Oropharyngeal pain
White blood cell count decreased
Pustular psoriasis (raised bumps on the skin that are filled with pus)
Hypoaesthesia (reduced sense of touch or sensation)
Hypoxia (low oxygen in tissues)
Immunosuppression

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 10.94%
Pain: 6 people, 9.38%
Insomnia (sleeplessness): 6 people, 9.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 7.81%
Diarrhea: 5 people, 7.81%
High Blood Pressure: 5 people, 7.81%
Weight Decreased: 4 people, 6.25%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 6.25%
Depression: 4 people, 6.25%
Diabetes: 4 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and Meloxicam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously